AbbVie - 6 Year Stock Price History | ABBV

Historical daily share price chart and data for AbbVie since 2013 adjusted for splits and dividends. Open, high, low, close (OHLC) data as well as percentage changes for multiple date ranges. Display 20, 50 and 200 day moving averages and export charts as images to use in articles and blogs. The latest closing price for AbbVie as of January 22, 2019 is 88.66.
AbbVie Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 87.9457 89.2300 90.7900 84.7600 88.6600 -3.83%
2018 96.6086 95.7421 120.7271 77.8500 92.1900 -2.02%
2017 72.2922 58.5607 95.5475 56.8887 94.0881 60.13%
2016 56.1176 52.0041 62.6502 46.7144 58.7578 9.88%
2015 55.2983 57.5628 63.6950 43.5730 53.4755 -6.46%
2014 47.8856 43.9710 60.9000 39.9325 57.1696 27.97%
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $134.627B $28.216B
AbbVie is a global, research-based biopharmaceutical company. AbbVie combines the focus and passion of a leading-edge biotech with the expertise and structure of a long-established pharmaceutical leader. The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases. AbbVie aims to help patients' live healthier lives and collaborate on sustainable healthcare solutions.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $350.628B 16.44
Pfizer (PFE) United States $253.175B 14.27
Novartis AG (NVS) Switzerland $205.567B 17.62
Merck (MRK) United States $204.560B 17.73
Eli Lilly (LLY) United States $123.506B 21.71
Novo Nordisk (NVO) Denmark $117.412B 19.07
Sanofi (SNY) France $104.035B 12.88
GlaxoSmithKline (GSK) United Kingdom $96.892B 13.02
AstraZeneca (AZN) United Kingdom $92.577B 11.49
Bristol-Myers Squibb (BMY) United States $81.806B 13.47